relapsed follicular B-cell non-Hodgkin's lymphoma (DBCOND0108695)
Identifiers
- Synonyms
- Relapsed follicular B-cell non-Hodgkin lymphoma / Relapsed Follicular B-cell Non-Hodgkin's Lymphoma
Associated Data
- Indicated Drugs and Targets
Drug Description Targets Ibritumomab tiuxetan A monoclonal anti-CD20 antibody used to treat B-cell non-Hodgkin's lymphoma via a conjugated radioactive isotope.Idelalisib An antineoplastic kinase inhibitor used to treat chronic lymphocytic leukemia (CLL), relapsed follicular B-cell non-Hodgkin lymphoma (FL), and relapsed small lymphocytic lymphoma (SLL).- Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoformtarget
- Broad substrate specificity ATP-binding cassette transporter ABCG2transporter
- ATP-dependent translocase ABCB1transporter
- Aldehyde oxidaseenzyme
- Cytochrome P450 2C8enzyme
- Cytochrome P450 2C19enzyme
- Cytochrome P450 2B6enzyme
- Cytochrome P450 3A4enzyme
- Solute carrier organic anion transporter family member 1B1transporter
- Solute carrier organic anion transporter family member 1B3transporter
- Cytochrome P450 3A5enzyme
- Cytochrome P450 3A43enzyme
- Cytochrome P450 3A7enzyme
- UDP-glucuronosyltransferase 1A4enzyme
Rituximab A monoclonal anti-CD20 antibody used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, Wegener's granulomatosis, pemphigus vulgaris, and rheumatoid arthritis.- Clinical Trials
- Not Available